TCGN yields 2000000.00% · JNJ yields 2.13%● Live data
📍 TCGN pulled ahead of the other in Year 1
Combined, TCGN + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TCGN + JNJ for your $10,000?
Technology General Corporation engages in the manufacture of deep-drawn metal-formed products, and ice crushing and shaving equipment; manufacture and distribution of spray coating and industrial mixer systems; and sale of its products to various users primarily in the United States. It operates in three divisions: Precision Metalform, Eclipse Systems, and Clawson Machine. The Precision Metalform division manufactures various deep drawn metal components used primarily in the writing instruments industry and cosmetic industry. The Eclipse Systems division manufactures products, including spray coating systems, and industrial air-driven and electric mixers. Its spray coating systems are used primarily for coating industrial products and the industrial mixers are used in the chemical and food processing industries. The Clawson Machine division produces a line of ice crushing equipment that is used by hotels, restaurants, cruise liners, and related sectors. The company markets its products directly and through a network of distributors. It also owns and leases its buildings to industrial tenants. The company was incorporated in 1957 and is based in Franklin, New Jersey.
Full TCGN Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.